<DOC>
	<DOCNO>NCT01479231</DOCNO>
	<brief_summary>The investigator determine prevalence gastroesophageal reflux disease ( GERD ) Eosinophilic Esophagitis ( EoE ) importantly determine predictor response Proton Pump Inhibitor ( PPI ) therapy EoE . Moreover , investigator determine effect GERD location esophageal eosinophilia .</brief_summary>
	<brief_title>Predictors Proton Pump Inhibitor ( PPI ) Response Eosinophilic Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Eosinophilic Esophagitis</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<criteria>18 year age &lt; 80 year age 14 eosinophil / hpf biopsy esophagus Abnormal validate Mayo dysphagia questionnaire ( MDQ30 ) ( question 2 '' yes '' , question 4 &gt; `` moderate '' question 7 &gt; `` week '' ) Clinically perform EGD &gt; 14 eosinophils/hpf complete within last 3 month Other cause dysphagia identify endoscopy ( e.g . stricture , web , infection , ring , achalasia , esophageal neoplasm ) Dilatation esophagus time index endoscopy Treatment topical steroid within 3 month index endoscopy Treatment PPI last 30 day prior index EGD Patient population adult EoE recruit Mayo Clinic Rochester , MN patient population</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>GERD</keyword>
	<keyword>Eosinophilic esophagitis</keyword>
	<keyword>Proton pump inhibitor</keyword>
	<keyword>dysphagia</keyword>
</DOC>